Recent Updates
Recently added Catalysts
MDXH Neutral Sentiment Score: 45/100

MDxHealth SA and Subsidiaries UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF PROFIT OR LOSS Three Months Ended March 31, In thousands of $ (except per share amounts) 2024 2023 Revenues $ 19,834 $ 14,700 Cost of sales (exc

Key Takeaway: MDxHealth SA reported its unaudited financial results for Q1 2024, showing a revenue increase to $19,834 from $14,700 in Q1 2023. Despite this growth, the company faced a net loss of $8,511, although it was an improvement from the previous year's loss of $11,709. The gross profit also improved, rising to $12,063 compared to $8,715 a year earlier. However, the decrease in cash and total equity raises concerns about the company's financial stability.

Market Sentiment Analysis

POSITIVE FACTORS

  • Revenues increased from $14,700 to $19,834 year-over-year.
  • Gross profit rose to $12,063, showing improvement.
  • Decrease in operating loss from $8,717 to $6,604 indicates a positive trend.

CONCERNS & RISKS

  • Despite increased revenues, the company reported a net loss of $8,511.
  • Cash and cash equivalents decreased significantly from $22,380 to $14,494.
  • Total equity decreased from $7,208 to -$973, suggesting declining financial health.

Full Press Release Details

CONDENSED CONSOLIDATED STATEMENT OF PROFIT OR LOSS
Three Months Ended March 31,
In thousands of $ (except per share amounts) 2024 2023
Revenues $ 19,834 $ 14,700
Cost of sales (exclusive of amortization of intangible assets) (7,771 ) (5,985 )
Gross profit 12,063 8,715
Research and development expenses (2,164 ) (1,316 )
Selling and marketing expenses (10,028 ) (9,099 )
General and administrative expenses (5,359 ) (5,169 )
Amortization of intangible assets (1,125 ) (1,124 )
Other operating income (expense), net 9 (724 )
Operating loss (6,604 ) (8,717 )
Financial expenses, net (1,907 ) (2,992 )
Loss before income tax (8,511 ) (11,709 )
Income tax - -
Loss for the period $ (8,511 ) $ (11,709 )
Loss per share attributable to parent*
Basic and diluted $ (0.31 ) $ (0.53 )
CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION
Thousands of $ March 31, 2024 December 31, 2023
ASSETS
Non-current assets
Goodwill $ 35,926 $ 35,926
Intangible assets 43,757 44,337
Property, plant and equipment 4,758 4,956
Right-of-use assets 4,625 4,989
Financial assets 693 763
Total non-current assets 89,759 90,971
Current assets
Inventories 3,044 2,779
Trade receivables 12,669 11,088
Prepaid expenses and other current assets 1,779 1,914
Cash and cash equivalents 14,494 22,380
Total current assets 31,986 38,161
TOTAL ASSETS $ 121,745 $ 129,132
EQUITY
Share capital $ 173,931 $ 173,931
Issuance premium 153,177 153,177
Accumulated deficit (339,957 ) (331,446 )
Share-based compensation 12,307 12,139
Translation reserve (431 ) (593 )
Total equity (973 ) 7,208
LIABILITIES
Non-current liabilities
Loans and borrowings 35,775 35,564
Lease liabilities 3,115 3,578
Other non-current financial liabilities 64,878 63,259
Total non-current liabilities 103,768 102,401
Current liabilities
Loans and borrowings 645 643
Lease liabilities 1,564 1,480
Trade payables 8,759 8,811
Other current liabilities 6,258 5,694
Other current financial liabilities 1,724 2,895
Total current liabilities 18,950 19,523
Total liabilities 122,718 121,924
TOTAL EQUITY AND LIABILITIES $ 121,745 $ 129,132
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
Three Months Ended March 31,
Thousands of $ For the years ended December 31 2024 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Operating loss $ (6,604 ) $ (8,717 )
Depreciation 775 512
Amortization of intangible assets 1,125 1,124
Share-based compensation 168 158
Other non-cash transactions (1 ) 815
Cash used in operations before working capital changes (4,537 ) (6,108 )
Increase (-) / decrease (+) in inventories (265 ) 297
Increase (-) / decrease (+) in receivables (1,392 ) 346
Increase (+) in payables 679 1,197
Net cash outflow from operating activities (5,515 ) (4,268 )
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment (220 ) (787 )
Acquisition and generation of intangible assets (544 ) (455 )
Interests received 146 4
Net cash outflow from investing activities (618 ) (1,238 )
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of shares, net of transaction costs - 39,599
Repayment of loan obligation (160 ) (158 )
Payment of lease liability (475 ) (348 )
Payment of interest (947 ) (831 )
Other financial expenses (170 ) -
Net cash (outflow) inflow from financing activities (1,752 ) 38,262
Net decrease (-) / increase (+) in cash and cash equivalents (7,885 ) 32,756
Cash and cash equivalents at beginning of period 22,380 15,503
Effect on exchange rate changes (1 ) (5 )
Cash and cash equivalents at end of period $ 14,494 $ 48,254

Frequently Asked Questions

What were the revenues for Q1 2024?

The revenues for Q1 2024 were $19,834,000.

How much was the operating loss in Q1 2024?

The operating loss in Q1 2024 was $6,604,000.

What is the total equity as of March 31, 2024?

The total equity as of March 31, 2024, is $(973,000).

What was the cash equivalent at the end of Q1 2024?

The cash equivalents at the end of Q1 2024 were $14,494,000.

Last updated: May 1, 2024